TSL3
 
3x Long TSLA
View TSL3
  • No need of a margin or CFD account.
  • Physically-backed products.
  • Traded on exchange like other stocks.
  • 21,269,370 shares held of TSLA
  • Trade
    in GBP, EUR & USD
Past performance is not indicative of future results.

Why 3x Long TSLA?

Potential Ways
to Gain Magnified Exposure		 Futures Option Spread Betting /
CFDs		 Warrants /
Turbos		 Leveraged
Certificates		 Leverage Shares
ETPs¹
Constant Leverage Factor
Losses Capped at Invested Amount
Low Minimum Trade Size
No Maintenance Margin Required
Physically-Backed
Dedicated Market Maker
No Bank Credit Risk²
Traded on a Regulated Exchange

¹ Leverage Shares are margin-based ETPs that provide 5x, 3x, 2x, -1x -2x, -3x & -5x exposure to individual stocks & ETFs.

² Although credit risk is reduced, other risks still apply.

All leveraged products carry significant risk of loss and may not be suitable for all investors.

Listings & Tickers

Country Exchange Base
Currency		 Trading
Currency		 Exchange
Code		 ISIN SEDOL BBG Ticker RIC WKN Listing Date
UK London Stock Exchange USD GBP 3TSL XS2757381400 BN6V0W9 3TSL LN 3TSL.L N/A 17 Mar 2021
UK London Stock Exchange USD EUR 3TSE XS2757381400 BN6V0X0 3TSE LN 3TSE.L N/A 17 Mar 2021
UK London Stock Exchange USD USD TSL3 XS2757381400 BN6V0V8 TSL3 LN TSL3.L N/A 17 Mar 2021
NL Euronext Amsterdam USD EUR 3TSL XS2757381400 BN6V0Y1 3TSL NA 3TSL.AS N/A 13 Apr 2021
DE Deutsche Börse Xetra USD EUR 3TSE XS2757381400 BN6V0Z2 3TSE GY 3TSE.DE A4AEJB 01 Jun 2022
IT Borsa Italiana USD EUR 3TSL XS2757381400 BN6V104 3TSL IM 3TSL.MI N/A 16 Feb 2022

Options for Buying
Leverage Shares ETPs

  • Consult your Financial Advisor

    Get a financial advice to receive a personalized guidance tailored to your specific circumstances.

  • Find your preferred Broker

    Use a broker that lets you effectively manage and execute your financial transactions.

  • Trade
    commission-free*

    There is no commission when you use Trading 212 account. * Other fees may apply

ETP Documents

Fact Sheet
Final Terms FCA Final Terms CBI
2026-10 UK DE ES FR IT NL PL SV
2026-09 UK DE ES FR IT NL PL SV
2026-08 UK DE ES FR IT NL PL SV
2026-07 UK DE ES FR IT NL PL SV
2026-06 UK DE ES FR IT NL PL SV
2026-05 UK DE ES FR IT NL PL SV
2026-04 UK DE ES FR IT NL PL SV
2026-03 UK DE ES FR IT NL PL SV
2026-02 UK DE ES FR IT NL PL SV
2026-01 UK DE ES FR IT NL PL SV
2025-12 UK DE ES FR IT NL PL SV
2025-11 UK DE ES FR IT NL PL SV
2025-10 UK DE ES FR IT NL PL SV
2025-09 UK DE ES FR IT NL PL SV
2025-08 UK DE ES FR IT NL PL SV
2025-07 UK DE ES FR IT NL PL SV
2025-06 UK DE ES FR IT NL PL
2025-05 UK DE ES FR IT NL PL
2025-04 UK DE ES FR IT NL PL
2025-03 UK DE ES FR IT NL PL
2025-02 UK DE ES FR IT NL PL
2025-01 UK DE ES FR IT NL PL
2024-12 UK DE ES FR IT NL PL
2024-11 UK DE ES FR IT NL PL
2024-10 UK DE ES FR IT NL PL
2024-09 UK DE ES FR IT NL PL
2024-08 UK DE ES FR IT NL PL
2024-07 UK DE ES FR IT NL PL
2024-06 UK DE ES FR IT NL PL
2024-05 UK DE ES FR IT NL PL
2024-04 UK DE ES FR IT NL PL
2024-03 UK DE ES FR IT NL PL
2024-02 UK DE ES FR IT NL PL
2024-01 UK DE ES FR IT NL PL
2023-12 UK DE ES FR IT NL PL
2023-11 UK DE ES FR IT NL PL
2023-09 UK DE ES FR IT NL PL
2023-08 UK DE ES FR IT NL PL
2023-07 UK DE ES FR IT NL PL
2023-06 UK DE ES FR IT NL PL
2023-05 UK DE ES FR IT NL PL
2023-04 UK DE ES FR IT NL PL
2023-03 UK DE ES FR IT NL PL
2023-02 UK DE ES FR IT NL PL
2023-01 UK DE ES FR IT NL PL
2022-12 UK DE ES FR IT NL PL
UK Fund Reporting
Reportable Income
EMT
Supplement (FCA) 07.07.2026 Supplement (CBI) 07.07.2026 Prospectus (CBI) 11.06.2026 Prospectus (FCA) 09.06.2026 Prospectus (FCA) 13.03.2026 Prospectus (CBI) 13.03.2026 Prospectus (FCA) 23.06.2025 Prospectus (CBI) 23.06.2025 Prospectus (CBI) 17.07.2024 Prospectus (FCA) 17.07.2024 Prospectus (CBI) 15.03.2024 Prospectus (FCA) 15.03.2024 Prospectus (FCA) 18.10.2023 Prospectus (CBI) 18.10.2023 Prospectus (FCA) 04.05.2023 Prospectus (CBI) 04.05.2023 Supplement 01.06.2022 Prospectus 16.05.2022 Prospectus 07.12.2021 Supplement 08.10.2021 Supplement 17.09.2021 Supplement 06.05.2021 Supplement 04.03.2021 Prospectus 18.12.2020 Prospectus 06.11.2020 Prospectus 05.02.2020
Half Financial Year Ended 31.12.2025 Financial Year Ended 30.06.2025 Half Financial Year Ended 31.12.2024 Financial Year Ended 30.06.2024 Half Financial Year Ended 31.12.2023 Financial Year Ended 30.06.2023 Half Financial Year Ended 31.12.2022 Financial Year Ended 30.06.2022 Half Financial Year Ended 31.12.2021 Financial Year Ended 30.06.2021 Half financial year ended 31.12.2020 Financial Year Ended 30.06.2020 Half Financial Year Ended 31.12.2019 For the Year Ended 30.06.2019 From 01.07.18 to 31.12.18 From 27.01.17 to 30.06.18

Notices

Latest Notice
18.09.2026 Batch Notification 11.09.2026 Notice Appointment of Authorised Participants 26.08.2026 Notification of New Series 21.07.2026 Batch Notification 19.06.2026 Notice to ETP Securityholders 03.06.2026 Notices of Investment Strategy Modifications 21.05.2026 Batch Notification 30.04.2026 Notification of New Series 24.03.2026 Notification of New Series 23.03.2026 Batch Notification 11.03.2026 Notices of Investment Strategy Modifications 31.10.2025 Notice of Publication of Audited Financial Statements 06.08.2025 Updated to IB Margin Account Agreement 08.05.2025 Notice Appointment of Additional Authorised Participant 08.05.2025 Notice Appointment of Additional Authorised Participant 08.05.2025 Notice Appointment of Additional Authorised Participant 08.05.2025 Notice Appointment of Additional Authorised Participant 16.01.2025 Notice to ETP Securityholders 02.10.2024 Notice of Amended & Restated Margin Account Agreement 29.07.2024 Notice of Appointment of Pershing as Additional Margin Load Provider 17.07.2024 Notice of Deed of Amendment and Restatement 10.07.2024 Notice of Increase in Margin Rate 28.03.2024 Notice of Clerical Errors 13.02.2024 Consolidation Notice 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 26.01.2024 Notice of Result of Adjourned Meeting 10.01.2024 Notice of Adjourned Meeting 10.01.2024 Notice of Adjourned Meeting 10.01.2024 Notice of Adjourned Meeting 12.12.2023 Notice of Split Meeting 12.12.2023 Notice of Split Meeting 12.12.2023 Notice of Split Meeting 02.11.2023 Notice of Late Filing of Audited Financial Report 27.10.2023 Notice of Amended Final Terms 19.10.2023 Notice to ETP Securityholders 20.09.2023 Notice of Migration to IB LLC 15.06.2023 Notice 3x Tesla 12.06.2023 Notice 3x Tesla 12.06.2023 Notice 3x Tesla 09.06.2023 Notice 3x Tesla 04.05.2023 Notice of Amended and Restated Conditions 13.12.2022 Notice of Result of Adjourned Meeting 13.12.2022 Notice of Result of Adjourned Meeting 13.12.2022 Notice of Result of Adjourned Meeting 13.12.2022 Notice of Result of Adjourned Meeting 09.12.2022 Notice of Extension of Deadline 29.11.2022 Notice of Delisting from Euronext Paris 12.10.2022 Intraday Rebalance 12.10.2022 Intraday Rebalance 12.10.2022 Intraday Rebalance 12.10.2022 Intraday Rebalance 19.08.2022 Notice of Mandatory Redemption 16.08.2022 Notice of Amended and Restated Master Trust Deed 08.08.2022 Mandatory Redemption 20.07.2022 Intraday Rebalance 18.07.2022 Intraday Rebalance 15.07.2022 Intraday Rebalance 01.07.2022 Intraday Rebalance 21.06.2022 Intraday Rebalance 14.06.2022 Notice of Delisting 14.06.2022 Notice of Delisting 13.06.2022 Intraday Rebalance 24.05.2022 Intraday Rebalance 13.05.2022 Intraday Rebalance 12.05.2022 Notice of Waiver of Arranger Fee 12.05.2022 Intraday Rebalance 09.05.2022 Intraday Rebalance 09.05.2022 Intraday Rebalance 05.05.2022 Intraday Rebalance 05.05.2022 Intraday Rebalance 05.05.2022 Notice of Issuer Call Redemption 27.04.2022 Notice of Issuer Call Redemption 20.04.2022 Intraday Rebalance 20.04.2022 Intraday Rebalance 29.03.2022 Notice of Waiver of Arranger Fee 23.03.2022 Notice of Series Name Change 16.03.2022 Intraday Rebalance 16.03.2022 Intraday Rebalance 14.03.2022 Intraday Rebalance 10.03.2022 Intraday Rebalance 07.03.2022 Notice of Delisting from CBOE Europe Limited. 18.02.2022 Intraday Rebalance 16.02.2022 Intraday Rebalance 03.02.2022 Intraday Rebalance 03.02.2022 Intraday Rebalance 02.02.2022 Intraday Rebalance 31.01.2022 Intraday Rebalance 21.01.2022 Intraday Rebalance 21.01.2022 Intraday Rebalance 31.12.2021 Intraday Rebalance 07.12.2021 Notice of Amended and Restated Terms and Conditions 05.12.2021 Notice to ETP Securityholders 05.12.2021 Notice of Intraday Rebalance and Issuer Call Redemption 23.11.2021 Notice of Intraday Rebalance 18.11.2021 Notice of Change of Portfolio Administrator 16.11.2021 Notice to ETP Securityholders 09.11.2021 Notice to ETP Securityholders 08.10.2021 Notice of Arranger Fee Increase 27.09.2021 Notice of Change of Portfolio Administrator 17.09.2021 Notice of Fee Increase 17.09.2021 Notice of Fee Decrease 31.08.2021 Intraday Rebalance 12.04.2021 Notice of Cross Listing 26.01.2021 Notice of Cross Listing (Euronext Paris) 12.01.2021 Notice of Cross Listing (Euronext Amsterdam) 23.12.2020 Notice of Termination of Service Providers 18.12.2020 Notice of Confirmation of Migration to ICSD 08.12.2020 Notice of Migration to ICSD 27.11.2020 Notice of Change of Issuing and Paying Agent 27.10.2020 Notice of Change of Service Providers

This is a marketing communication. Prospective investors should refer to the Exchange Traded Product ("ETP") Prospectus and Key Investor Information Document (KIID) before making any investment decisions.

No Legal or Investment Advice
The information on this website does not constitute legal, financial, or investment advice. It should not be considered an offer to sell or a solicitation to buy any security, including shares of any ETP promoted here, or other financial instruments, products, or services offered by Leverage Shares or its distributors ("Leverage Shares").

Investment Advice & Client Services
Leverage Shares constructs and issues ETPs but does not provide services to private investors, nor does it accept client funds directly. Leverage Shares’ services are exclusively available to professional clients, as defined in this website’s Terms and Conditions. Private investors should consult their personal advisor, broker, or bank for investment or trading inquiries. For technical questions regarding our ETPs, please contact us directly.

Investment Decisions
Any investment in promoted ETPs should be based on the official sales Prospectus, the relevant Supplement, and the KIID, which outline the applicable terms and conditions.

Investment Risks
Investments in ETPs are subject to risk, including potential loss of principal. The value of investments may fluctuate, and investors may not recover the amount originally invested. Past performance is not indicative of future results and should not be the sole factor considered in selecting a product. Investors should carefully consider their investment objectives, risks, charges, and expenses before investing.

Documentation & Availability
The Prospectus, KIID, and other relevant documentation are available free of charge on this website, and upon request via email. Please note that except for KIIDs, documents are generally available in English and selected other languages.

Regulatory Information
Investium Limited, has been appointed as distributor of Leverage Shares products in Europe.Investium Limited, with registered address at 6 Nikou Georgiou Street, Office 302, 1095 Nicosia Cyprus, is a financial services provider regulated by the Cyprus Securities and Exchange Commission (CySEC).

Not Insured — No Bank Guarantee — May Lose Value

© Leverage Shares 2026